- Sharpened product candidate focus on its next-generation ADC portfolio, following strategic review and pipeline reprioritization -
Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights
Seeking Alpha / 5 minutes from now 1 Views
Comments